Standard BioTools Inc.
General ticker "LAB" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $495.6M (TTM average)
Standard BioTools Inc. follows the US Stock Market performance with the rate: 49.6%.
Estimated limits based on current volatility of 4.5%: low 1.03$, high 1.13$
Factors to consider:
- Total employees count: 818 as of 2024
- North and South America accounted for 53.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Product development delays, Market competition, Market development, Climate change and natural disasters
- Current price 12.6% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.17$, 2.40$]
- 2026-12-31 to 2027-12-31 estimated range: [1.09$, 2.25$]
Short-term LAB quotes
Long-term LAB plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $85.33MM |
| Operating Expenses | $178.64MM |
| Operating Income | $-93.31MM |
| Non-Operating Income | $-3.40MM |
| Interest Expense | $0.03MM |
| R&D Expense | $25.99MM |
| Income(Loss) | $-96.70MM |
| Taxes | $-37.88MM |
| Profit(Loss)* | $-74.90MM |
| Stockholders Equity | $424.29MM |
| Inventory | $19.98MM |
| Assets | $567.75MM |
| Operating Cash Flow | $-74.35MM |
| Capital expenditure | $8.30MM |
| Investing Cash Flow | $24.77MM |
| Financing Cash Flow | $0.57MM |
| Earnings Per Share** | $-0.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.